Publication: Branimycins B and C, Antibiotics Produced by the Abyssal Actinobacterium Pseudonocardia carboxydivorans M-227.
dc.contributor.author | Braña, Alfredo F | |
dc.contributor.author | Sarmiento-Vizcaíno, Aida | |
dc.contributor.author | Pérez-Victoria, Ignacio | |
dc.contributor.author | Otero, Luis | |
dc.contributor.author | Fernández, Jonathan | |
dc.contributor.author | Palacios, Juan José | |
dc.contributor.author | Martín, Jesús | |
dc.contributor.author | de la Cruz, Mercedes | |
dc.contributor.author | Díaz, Caridad | |
dc.contributor.author | Vicente, Francisca | |
dc.contributor.author | Reyes, Fernando | |
dc.contributor.author | García, Luis A | |
dc.contributor.author | Blanco, Gloria | |
dc.date.accessioned | 2023-01-25T09:43:22Z | |
dc.date.available | 2023-01-25T09:43:22Z | |
dc.date.issued | 2017-02-07 | |
dc.description.abstract | Two new antibiotics, branimycins B (2) and C (3), were produced by fermentation of the abyssal actinobacterium Pseudonocardia carboxydivorans M-227, isolated from deep seawater of the Avilés submarine Canyon. Their structures were elucidated by HRMS and NMR analyses. These compounds exhibit antibacterial activities against a panel of Gram-positive bacteria, including Corynebacterium urealyticum, Clostridium perfringens, and Micrococcus luteus, and against the Gram-negative bacterium Neisseria meningitidis. Additionally, branimycin B displayed moderate antibacterial activity against other Gram-negative bacteria such as Bacteroides fragilis, Haemophilus influenzae, and Escherichia coli, and branimycin C against the Gram-positive Enterococcus faecalis and methicillin-sensitive and methicillin-resistant Staphylococcus aureus. | |
dc.identifier.doi | 10.1021/acs.jnatprod.6b01107 | |
dc.identifier.essn | 1520-6025 | |
dc.identifier.pmid | 28169531 | |
dc.identifier.unpaywallURL | https://digibuo.uniovi.es/dspace/bitstream/10651/42955/1/proofs%20branimycins%20B%20and%20C%20.pdf | |
dc.identifier.uri | http://hdl.handle.net/10668/10849 | |
dc.issue.number | 2 | |
dc.journal.title | Journal of natural products | |
dc.journal.titleabbreviation | J Nat Prod | |
dc.language.iso | en | |
dc.organization | Fundación MEDINA (Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía) | |
dc.organization | Fundación MEDINA | |
dc.page.number | 569-573 | |
dc.pubmedtype | Journal Article | |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.subject.mesh | Anti-Bacterial Agents | |
dc.subject.mesh | Enterococcus faecalis | |
dc.subject.mesh | Gram-Negative Bacteria | |
dc.subject.mesh | Gram-Positive Bacteria | |
dc.subject.mesh | Haemophilus influenzae | |
dc.subject.mesh | Macrolides | |
dc.subject.mesh | Methicillin-Resistant Staphylococcus aureus | |
dc.subject.mesh | Microbial Sensitivity Tests | |
dc.subject.mesh | Molecular Structure | |
dc.subject.mesh | Nuclear Magnetic Resonance, Biomolecular | |
dc.title | Branimycins B and C, Antibiotics Produced by the Abyssal Actinobacterium Pseudonocardia carboxydivorans M-227. | |
dc.type | research article | |
dc.type.hasVersion | SMUR | |
dc.volume.number | 80 | |
dspace.entity.type | Publication |